Yuki Oichi

Yuki Oichi

Auto-generated profile, based on publicly available information

Yuki Oichi

Department of Neurosurgery, Hyogo Prefectural Amagasaki General Medical Center

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
MTMidori Takeda
Midori Takeda
TTTohru Tezuka
Tohru Tezuka
MINSOO KIMMINSOO KIM
MINSOO KIM
JCJungmi Choi
Jungmi Choi
YOYuki Oichi
Yuki Oichi
SYShohab Youssefian
Shohab Youssefian
Moyamoya disease (MMD) is a cerebrovascular disease characterized by progressive occlusion of the internal carotid arteries. Genetic studies originally identified RNF213 as an MMD susceptibility gene that encodes a large 591 kDa protein with a functional RING domain and dual AAA+ ATPase domains. As the functions of RNF213 and its relationship to MMD onset are unknown, we set out to characterize the ubiquitin ligase activity of RNF213, and the effects of MMD patient mutations on these activities and on other cellular processes. In vitro ubiquitination assays, using the RNF213 RING domain, identified Ubc13/Uev1A as a key ubiquitin conjugating enzyme that together generate K63-linked polyubiquitin chains. However, nearly all MMD patient mutations in the RING domain greatly reduced this activity. When full-length proteins were overexpressed in HEK293T cells, patient mutations that abolished the ubiquitin ligase activities conversely enhanced nuclear factor κB (NFκB) activation and induced apoptosis accompanied with Caspase-3 activation. These induced activities were dependent on the RNF213 AAA+ domain. Our results suggest that the NFκB- and apoptosis-inducing functions of RNF213 may be negatively regulated by its ubiquitin ligase activity and that disruption of this regulation could contribute towards MMD onset.

23 April 2025 in Stroke and Vascular Neurology
Verified
Journal Article
Open access
PDF file
YMYohei Mineharu
Yohei Mineharu
TKTakahiko Kamata
Takahiko Kamata
MTMei Tomoto
Mei Tomoto
NSNoriaki Sato
Noriaki Sato
YTYoshinori Tamada
Yoshinori Tamada
YAYoshiki Arakawa
Yoshiki Arakawa
Background: The p.R4810K founder mutation in the RNF213 gene confers susceptibility to moyamoya disease (MMD) and non-MMD intracranial artery disease. However, penetrance is incomplete, and the underlying molecular mechanism remains unknown. Methods and results: Transcriptome analysis of peripheral blood was conducted with nine MMD patients and five unaffected mutation carriers from four familial MMD pedigrees. Bayesian network analysis identified upregulated gene modules associated with lipid metabolism and leucocyte development (including GATA2 and SLC45A3 ), and epidermal growth factor receptor (EGFR) signalling ( UBTD1 ). It also identified downregulated gene modules related to mitochondrial ribosomal proteins ( RPS3A and RPL26 ), and cytotoxic T cell immunity ( GZMA and TRGC1 ). The GATA2 network was replicated through weighted gene co-expression network analysis and further examined in a case–control study, comprising 43 MMD patients, 16 non-MMD patients, 19 unaffected carriers and 35 healthy controls. GATA2 exhibited a significant linear correlation with SLC45A3 and was significantly higher in MMD patients compared with age-matched and sex-matched unaffected carriers or wild-type controls. Among patients with the p.R4810K mutation, higher GATA2 expression was associated with an earlier age of onset, bilateral involvement and symptomatic disease onset. Conclusions: Peripheral blood GATA2 expression was associated with increased penetrance of the RNF213 mutation and more severe clinical manifestations in MMD.

15 December 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YOYuki Oichi
Yuki Oichi
YMYohei Mineharu
Yohei Mineharu
YAYuji Agawa
Yuji Agawa
TMTakaaki Morimoto
Takaaki Morimoto
TFTakeshi Funaki
Takeshi Funaki
SMSusumu Miyamoto
Susumu Miyamoto
It has long been believed that the bony carotid canal has no plasticity and that a small canal represents a hypoplastic internal carotid artery. We aimed to show whether the carotid canal can narrow according to morphological changes in the internal carotid artery. The carotid canal diameter was longitudinally measured in seven individuals who underwent carotid artery ligation. As moyamoya disease is known to be associated with negative remodeling of the internal carotid artery, the carotid canal diameter was measured in 106 patients with moyamoya disease, and an association with the outer diameter of the internal carotid artery or a correlation with the disease stage was investigated. The carotid canal was measured by computed tomography (106 patients), and the outer diameter of the artery was measured by high-resolution magnetic resonance imaging (63 patients). The carotid canal area was calculated by the product of the maximum axial diameter and its perpendicular diameter. All seven patients who underwent carotid artery ligation showed narrowing of the carotid canal, and the carotid canal area decreased by 12.2%–28.9% during a mean follow-up period of 4.2 years. In patients with moyamoya disease, the carotid canal area showed a linear correlation with the outer area of the internal carotid artery (r = 0.657, p < 0.001), and a negative correlation with the disease stage (ρ = −0.283, p < 0.001). The bony carotid canal has plasticity, and its area reflects the outer area of the internal carotid artery, therefore, it can be used to assess the remodeling of the carotid artery. A narrow carotid canal may not necessarily indicate hypoplastic internal carotid artery.

31 December 2018 in Neurospine
Verified
Journal Article
Open access
PDF file
YOYuki Oichi
Yuki Oichi
JHJunya Hanakita
Junya Hanakita
TTToshiyuki Takahashi
Toshiyuki Takahashi
MMManabu Minami
Manabu Minami
TKTaigo Kawaoka
Taigo Kawaoka
YOYasufumi Ohtake
Yasufumi Ohtake
Objective: Computed tomography following myelography (CM) revealed an unusual flow of contrast dye into the anterior median fissure (AMF) in a patient with cervical spondylotic myelopathy. Since then, several AMF configurations have been observed on CTM. Therefore, we evaluated morphological patterns of the AMF on CTM and investigated the significance and mechanisms of contrast dye flow into the AMF. Methods: Morphological patterns of the AMF on CTM were examined in 79 patients. Group A (24 patients) underwent surgery because of symptomatic cervical myelopathy. Group B (43 patients) had no clinical symptoms but showed spinal cord compression on CTM. Group C (12 patients), who showed neither clinical symptoms nor cord changes, underwent CTM for lumbar lesion evaluation. AMF patterns were classified into 4 types according to their configurations on GEM (reversed T, Y, V, and O types). Results: In group B, the reversed T type and Y type appeared significantly more often near the compressed portion (p<0.001). A similar tendency was seen in group A. The V and 0 types were most frequently observed in group C (p<0.001). Conclusion: On CTM, contrast dye tends to flow into the AMF of the cervical cord when the spinal cord is compressed. We speculate that there may be 3 possible mechanisms for this phenomenon: deformation of the epipial layer of the AMF due to cervical cord compression, AMF dilatation due to atrophy of the anterior funiculus or anterior horn, and temporary AMF dilatation when it becomes an alternative route for cerebrospinal fluid circulation.

1 August 2016
Verified
Journal Article
Closed access
TTToshiyuki Takahashi
Toshiyuki Takahashi
JHJunya Hanakita
Junya Hanakita
YOYasufumi Ohtake
Yasufumi Ohtake
YFYusuke Funakoshi
Yusuke Funakoshi
YOYuki Oichi
Yuki Oichi
MMManabu Minami
Manabu Minami

1 January 2018 in Journal of Neuroendovascular Therapy
Verified
Journal Article
Open access
PDF file
YOYuki Oichi
Yuki Oichi
MHMakoto Hayase
Makoto Hayase
AMAkinori Miyakoshi
Akinori Miyakoshi
KGKohichi Go
Kohichi Go
TKTakeshi Kawauchi
Takeshi Kawauchi
HTHiroki Toda
Hiroki Toda
Objective: We retrospectively compared the results of treatment between patients aged ≥85 years and those aged <85 years among those who underwent thrombectomy for acute cerebral infarction in our hospital. Methods: Of patients with acute cerebral infarction who underwent thrombectomy in our hospital between October 2014 and September 2017, the subjects were those with an interval of ≤8 hours from onset until arrival, a diffusion-weighted imaging-alberta stroke program early CT score (DWI-ASPECTS) of ≥6, and occlusion of the internal carotid (IC) artery, middle cerebral artery M1/M2, basilar artery (BA), or posterior cerebral artery P1. Results: The subjects consisted of 12 patients aged ≥85 years and 27 aged <85 years, with mean ages of 88.5 and 72.3 years, respectively. The rate of patients who had taken antithrombotic drugs before onset was significantly higher in the latter. There were no significant differences in the diagnosis, risk factors, modified Rankin Scale (mRS) score before onset, National Institute of Health Stroke Scale (NIHSS) score on arrival, DWI-ASPECTS, or site of occlusion. Concerning treatment results, the mRS score on discharge was significantly higher in those aged ≥85 years, but there were no significant differences in the recanalization rate or incidence of hemorrhagic complications between the two groups. Conclusion: In those aged ≥85 years, the mRS score on discharge was significantly higher. However, the recanalization rate was relatively high, and an improvement in the NIHSS score was achieved. Although the indication of thrombectomy should not be restricted based on the age alone, acute cerebral infarction patients aged ≥85 years must be accumulated to evaluate whether the procedure should be indicated.